Treatment with the fluorinated steroid triamcinolone (TR) induced type lib fiber atrophy and the con tractile profile of a slow muscle in rat diaphragm. In contrast, the nonfluorinated steroid prednisolone (PR) caused myogenic changes w ithout fiber atrophy, and increased fatigability. The aim of the pres ent study was to investigate the extent to which these changes were reversed 2 mo after discontinua tion of treatm ent. Adult rats were randomly assigned to receive saline, PR 1.25 or 5 mg/kg, or TR 0.25, 0.5, or 1 mg/kg, intramuscularly daily during 4 wk. Administration of TR resulted in severe loss of body weight and dose-dependent mortality. During recovery, body weight in the TR groups increased gradu ally, still remaining reduced compared with the other groups. Two months after discontinuation of treatment, diaphragm weight was increased in proportion to body weight. Twitch characteristics, max imal tetanic force, force-frequency curve, and fatigue resistance of isolated diaphragm bundles were similar in all groups. Histologic examination of the diaphragm revealed no gross abnormalities in the PR and TR groups. Mild but significant type lib fiber atrophy was still present in the diaphragm and gastrocnemius muscle of all TR-treated animals. In conclusion, recovery of alterations in morphology of respiratory and peripheral skeletal muscles induced by administration ofTR is prolonged. Dekhuijzen PNR, Cayan-Ram irez C, Bisschop A, de Bock V, Dom R, Decram er M. Recovery of cortico steroid-induced changes in contractile properties and morphology of rat diaphragm. AM J RESPIR CRIT CARE MED 1 9 9 6 ;1 5 3 :7 6 9 -7 5 .
roids are frequently administered in patients with asthma and chronic obstructive pulmonary disease (COPD). If recovery of the previous course of steroids is not complete at the time the second burst is given, steroid-induced changes in the diaphragm may superimpose, perhaps even more so in patients with COPD in whom respiratory muscle function may already be compro mised.
The aim of the present study, therefore, was to investigate whether in rats contractile properties of diaphragm and morpho logic characteristics of diaphragm and gastrocnemius were still affected 2 mo after discontinuation of a 4-wk treatment period with nonfluorinated (prednisolone) and fluorinated (triamcino lone) steroids.
METHODS

Study Design, Animals, and Treatment
One hundred twenty adult male Wistar rats, age 14 wks, were randomized in quadruplets, into one of four treatment groups: control (saline 0.05 ml/d intramuscularly), prednisolone (PR): 1.25 mg/kg/d intramuscu larly, PR 5 m g/kg/d intramuscularly, or triamcinolone diacetate (TR) 1 m g/kg/d intramuscularly. These dosages were chosen to compare the effects o f similar anti-inflammatory closes o f fluorinated (TR 1 tng/kg) and nonfluorinated steroids (PR 1.25 nig/kg) (12) as well as a fourfold higher dose o f the latter (PR 5 mg/kg). Animals were randomly allo cated to be investigated immediately after the 4-wk treatment period or to be followed in order to study the recovery period. The acute effects o f treatment were reported in a previous communication (5) . The pres ent study addresses the recovery o f the induced changes.
Because 12 o f the 15 animals in the TR 1.0 mg/kg group died during the active treatment period, a second series of similar experiments in an additional 45 rats was performed with lower dosages of TR: control 770 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 153 1996 (saline 0.05 ml/d intramuscularly), TR: 0.25 m g/kg/d intramuscularly, or TR: 0.5 m g/kg/d intramuscularly.
Dilution of medication was performed such that with each injection all animals received approximately a similar volume (0.05 ml). During 4 wk the animals were injected daily in the left hindlimb. After this period, treatment was discontinued. TWo months after discontinuation contractile properties, histologic, and histochemical characteristics of the diaphragm were examined. During the whole study period the animals were fed ad libitum. They were weighed twice weekly during the treatment period, and once weekly during the recovery period.
Contractile Properties
Rats were anesthetized with sodium pentobarbital (Nembutal, 60 mg/kg intraperitoneally). Animals were tracheotomized, and a tracheal can nula (polyethylene tubing PE-200) was inserted. They were mechanically ventilated with an 0 2-enriched gas mixture (Harvard pump respirator, South Natick, MA).
The diaphragm was quickly removed through a laparotomy, and im mediately immersed in a cooled (+ 4° C), oxygenated Krebs solution containing (in mMol/L): NaCl 137, KC14, CaCl2 2, MgCl2 1, KH2P 0 4 1, N aH C 03 12, glucose 6.5. To avoid regional differences in cross-sectional area or fiber type proportions as much as possible, two small rectangu lar bundles from the middle part of the lateral costal region were ob tained by dissection parallel to the long axis o f the fibers. Silk sutures were tied to both ends of the bundle to serve as anchoring points. This preparation was completed within 5 min. Subsequently, each bundle was placed within the external chamber of a jacketed tissue bath containing Krebs solution, maintained at 37° C and perfused with a 95% 0 2 and 5% C 0 2 mixture. Krebs solution was changed with each new bundle. One end of the bundle was tied to a rigid support, while the other was fastened to an isometric force transducer. Both anchoring points were mounted to two separate micrometers. The muscle was placed in be tween two large platinum stimulating electrodes.
The bundles were placed at their optimal length (L0), defined as the length at which peak twitch force was obtained. This was followed by a 15-min thermoequilibration period. Stimulations were delivered through a Harvard 50-5016 stimulator (Edenbridge, Kent, UK), connected in se ries to a power amplifier (power one model HS24-4.8; R. J. Evans, Univer sity of Virginia). Stimuli were applied with a pulse duration of 0.2 ms and a train duration of 250 ms. Maximum twitch force was achieved at ± 34 V. The voltage was then increased by 20% to ensure supramax imal stimulation. This voltage was subsequently used during all stimu lations. Isometric force was measured by means o f a Maywood force transducer (Maywood Ltd., Hampshire, UK). The signal was amplified and recorded on computer via analog to digital conversion (DT2801-A) using Labdat software (Labdat/Anadat; RHT-InfoDat, Montreal, Can ada). Signal analysis was done with Anadat.
The following measurements were performed:
TWitch characteristics: TWo twitches were recorded to determine maximal twitch force (Pt), time to peak tension (TPT), and half relaxation time (1/2RT). Average values were used for further analysis.
Maximal tetanic force (P0): Bundles were stimulated twice tetanically at 160 Hz, during 250 ms in order to obtain a clear plateau in force generation (13, 14) .
Force-frequency curve: Bundles were stimulated at the following fre quencies: 25,160,50,160,80,160,120, and 160 Hz (15). Each stimu lus was separated by a 2-min interval.
Fatigue properties: Fatigability was assessed in two different ways.
First, force output at 160 Hz was measured after each stimulus fre quency during the force-frequency curve (see above). This protocol allowed calculation of the actual force generation as a percentage o f the maximal force generation at that instance (15) . Second, bun dles were fatigued by means of 330-ms stimulations repeated every second at 25 Hz during 5 min (modified after Burke and coworkers [16] ).
The whole sequence of this contractile protocol took approximately 1 h. After these measurements, each muscle bundle was removed from the bath, keeping its length at L0. Bundle length was read from the two micrometers to which the bundle was mounted; its thickness and width were measured with a hand micrometer. The bundle was blotted dry and weighed. Cross-sectional area (CSA) was calculated by dividing weight by specific density (1.056) and muscle length. Forces were expressed per unit CSA (3, 15) . Twitch-to-tetanus ratio (Pt/P0) was calculated for each muscle bundle.
Finally, the remaining diaphragm tissue was trimmed, blotted, and weighed. Parasternal muscles (including sternum and chondral parts of the ribs), right medial scalene muscle, and the muscles gastrocnemius and soleus from the right hindlimb were dissected, trimmed, blotted, and weighed. 
Histologic and Histochemical Procedures
Data Analysis
Two diaphragm bundles were obtained from each animal for measure ments of contractile properties. Mean values from each animal were taken for statistical analysis. Data from the different treatment groups were compared, using one-way analysis of variance. Differences between means were assessed using Duncan's multiple range test. Statistical significance was set at p < 0.05. All analyses were performed using the S P S S /P C + package (18) . Means ± SD are represented in text, tables, and figures, unless otherwise specified.
RESULTS
Body and Muscle W eight
Body weight increased in both control and prednisolone groups during the treatment period (Table 1 ). In contrast, it decreased in all triamcinolone groups (p < 0.001). Mortality was observed only in the triamcinolone groups, and was 3 of 15 (20%), 9 of 15 (60%), and 12 of 15 (80%) in the TR 0.25, 0.5, and 1 mg/kg groups, respectively. Mortality occurred throughout the period control, PR 1.25 mg/kg, PR 5 mg/kg, and TR 1 mg/kg, respec tively. The TR group showed the smallest decline (p < 0.05 comof administration of triamcinolone; only one animal died (one pared with PR 5 mg/kg). In the second series of experiments, day) after the last administration of TR 0.5 mg/kg. Postmortem these percentage decreases in maximal tetanic force were 9.0 (1.1), 9.1 (1.2), and 9.0 (1.0), in control, TR 0.25 mg/kg and TR 0.5 examination of these animals was not performed. After discon tinuation of steroid treatment, body weight in the triamcinolone groups increased gradually, reaching a final body weight approx imately 1 to 8% above starting body weight. No change in growth occurred in the prednisolone groups after discontinuation of treatment.
Respiratory and peripheral muscle weight are shown in Table  2 . All muscle weights were clearly reduced in the triamcinolonetreated animals, except for soleus weight. When corrected for body weight, however, muscle weights were similar in all groups.
Physical activity of the animals was not measured in a stan dardized fashion. Roughly estimated, no changes occurred dur ing the treatment and recovery period.
Diaphragmatic Contractile Properties
Bundle dimensions. Bundle dimensions were similar in all groups (Table 3 ). Bundle weight was slightly lowered in the TR 0.5 and in the TR 1.0 mg/kg groups.
Twitch characteristics and maximal tetanic force. No signifi cant differences were found in twitch characteristics among the different treatment groups ( Table 4 ). The prolonged 1/2RT pre viously found after treatment with triamcinolone was not pres ent after recovery.
Force-frequency curve. The response of diaphragm strips to increasing stimulus frequencies is shown in Figure 1A Fatigue run. During the low-frequency fatigue run, force gener ation in all groups was similar, both when expressed in absolute values (Figure 2A, B) or as a percentage of initial values (data not shown).
Histopathology and Morphometry
Histologic examination of hematoxylin-eosin stained slides showed a normal muscular pattern in all treatment groups.
Fiber type distribution was not changed by different treat ments. In general, the diaphragm consisted of ~40% type I fibers, ~30% type I la fibers, and ~30% type lib fibers. In the gastroc nemius muscle, these percentages were ~30, ~25, and ~45% , respectively. Diaphragm fiber dimensions were affected differ ently according to the type of steroid administered. Mean CSA of type I, Ila, and lib fibers were similar in both control and prednisolone groups (Figure 3 A, B) . In all TR groups, however, type lib CSA was significantly reduced compared with the respec tive control groups (p < 0.05). Type I and Ila diameters were un affected by treatment with TR. A similar pattern of isolated type lib fiber atrophy was observed in the gastrocnemius in all TR groups (p < 0.05) ( Figure 4A, B) .
DISCUSSION
The present study shows the differences in recovery of steroidinduced changes in morphology and contractile properties of rat diaphragm when administering triamcinolone and prednisolone. Two months after discontinuation of administration of all dosages of triamcinolone studied, mild but significant selective type Mb fiber atrophy of the diaphragm is still present. Func tional differences are not present among the groups. Similar mor phologic changes are found in the gastrocnemius. In contrast, no histologic or functional changes are observed after complete withdrawal of prednisolone, which is in accord with the subtle changes associated with acute administration of this steroid. Mortality induced by triamcinolone appeared to be high and dose-related. The cause of this mortality is not clear. Severe (re spiratory) muscle wasting may possibly lead to respiratory fail ure, although we did not investigate this possibility. In addition, a reduction in the function of the immune system might play a role. Previous animal studies have shown that treatment with fluorinated steroids causes profound changes in diaphragm structure and function (1, 2, 4, 5, 7) . In these studies diaphragm weight was reduced by approximately 30 to 40% as a result of type lib fiber atrophy, resulting in a relative predominance of fatigueresistant muscle fibers. This was reflected by an increase in 1/2RT, prolongation of time to peak tension, and reduced fatigability of the diaphragm. The generalized fiber atrophy in hamsters found by Lewis and coworkers (4) may be explained by the young age (7 wk) of the animals. The acute effects of a 4-wk treatment period with triamcinolone 0.5 and 0.25 mg/kg/d were not inves tigated in the present study. The effects of 6-wk administration of triamcinolone 0.5 mg/kg/d, however, have recently been de scribed (7) . Severe myogenic changes were observed in the di aphragm of the rats, similar to the effects described after 4 wk administration of triamcinolone 1 mg/kg/d (5) . It is conceiv-lar changes appears to be slow. After acute steroid myopathy, able that similar changes would have occurred after a treatment electromyographic examination of peripheral skeletal muscle still period of 4 wk. Although we did not study the acute effects of showed abnormalities 6 mo after complete withdrawal of stetreatment during 4 wk with triamcinolone 0.25 mg/kg/d, the re-roid treatment (8) . Similarly, in chronic steroid myopathy recovsidual type lib fiber atrophy in this group after the follow-up ery of respiratory and peripheral muscle strength may take up period would suggest that more pronounced type lib fiber atro-to 3 to 6 mo (9, 10) . This was confirmed in a recent prospective phy has occurred after the acute treatment period. A recent study study by Weiner and coworkers (11) . These investigators studied showed that this dose of triamcinolone caused a reduction in body the effects of prednisone 1 to 1.5 m g/kg/d administered during weight of ~2 6% after a 2-wk treatment period (19) . This was 8 wk in patients with no underlying lung diseases. Treatment with accompanied by an increase in glutamine and phenylalanine ef-prednisone clearly reduced inspiratory muscle strength and enflux from the diaphragm, indicating an increased diaphragm pro-durance. Subsequent tapering down of the dosage to complete tein degradation rate. The changes in body and muscle weight withdrawal within 6 wk resulted in a gradual improvement of occurring in the present study further support the presence of respiratory muscle function. This improvement was continued alterations in muscle structure after triamcinolone treatment. In even 6 mo after complete withdrawal (11) . Histologic data with conclusion, although we did not study the acute effects of 4 wk regard to morphologic features in respiratory or peripheral skeletreatment with triamcinolone 0.5. and 0.25 mg/kg/d, the data tal muscles several months after discontinuation of steroids in from previous studies and the changes in body and muscle weight patients are not available. in the present study support the contention that acute changes Steroid-induced changes in structure and function of the di-(i.e., type lib fiber atrophy) were likely to be present after 4 wk aphragm are of specific clinical interest in patients with COPD. of treatment, and that persistent atrophy of these fibers present Treatment with systemic steroids is frequently indicated in these after the 2-mo follow-up period indicates an incomplete struc-patients. Diaphragm function in these patients, however, is comtural recovery.
promised by malnutrition (27, 28) , hyperinflation (29), distur-Changes induced by nonfluorinated steroids appear to be bances in blood gases (30) , and cardiac failure (31, 32) . In addidifferent, depending on the amount of steroid administered. High tion, age itself may affect respiratory muscle strength (33) . It may doses of (hydro)cortisone acetate (10 to 100 mg/kg intramuscu be expected that the effects of steroids on the already comprolarly) also reduce diaphragm weight by approximately 30 to 40% mised diaphragm may be more pronounced (34). The unfavora- (15, (20) (21) (22) . Atrophy of all fiber types was found in rabbit di-ble effects of steroids on the diaphragm might then be enhanced aphragm (21) , whereas no morphometry was performed in the if a subsequent course of steroids would be administered before other studies. In contrast, prednisolone, administered intramus-the diaphragm has recovered completely from the previous treatcularly in a dose of 5 mg/kg/d during 4 wk, caused myogenic ment with steroids. Physical inactivity, which may accompany changes in the diaphragm, consisting of greater than normal vari-recurrent exacerbations, leads to an increase of the number of ation of the diameter of all fiber types, excess of nuclei, and in-steroid receptors on skeletal muscle (35) . If a similar mechanism creased amount of connective tissue (5) . Generalized or selective would also occur in the diaphragm and the other respiratory musatrophy did not occur. Functionally, these changes were accom-cles, this would enhance the steroid-induced effects even further. panied by an increased tendency toward fatigue.
In conclusion, the present study shows that discontinuation Bundle dimensions themselves may affect contractile prop-of triamcinolone treatment for a period of 2 mo does not allow erties. Segal and Faulkner (23) studied the effect of muscle thick-the diaphragm to regain its normal structure completely. The ness and incubation temperature on the contractile properties acute effects of prednisolone on the diaphragm, however, apof rat skeletal muscles. The critical radius for 0 2 diffusion (i.e., the distance into a muscle at which 0 2 tension declined to zero) was ~0.60 mm at 37° C. This is clearly above the radius of the bundles in our study, which was ~0.25 mm. It seems therefore unlikely that the small differences in bundle weight and conse quent differences in oxygen diffusion would account for the ob served changes in contractile properties.
The pattern of recovery after cessation of fluorinated and non fluorinated steroids was not studied before in animal models. In the present study, 2 mo after discontinuation of triamcino lone, residual type lib fiber atrophy was still present. Appar ently, the degree of decrease in type lib fiber size was too small to result in pronounced changes in contractile properties. In con trast, no histologic or functional changes were observed after complete withdrawal of prednisolone. The latter finding is in agreement with the small changes associated with acute treatment.
In most of the abovementioned animal studies high or even massive doses of steroids were administered. Consequently, acute atrophy and rhabdomyolysis might have been induced in these studies. This has also been observed in patients with acute air ways obstruction, treated with massive doses of corticosteroids (8, (24) (25) (26) . This pattern of acute generalized muscle atrophy and weakness, however, is distinctly different from the clinical pat tern observed during chronic steroid myopathy. The latter oc curs after prolonged administration of steroids, and is charac terized by the insidious onset of muscle weakness predominantly localized in the proximal extremities (9) .
In patients, recovery of both types of steroid-induced muscu-pear to have resolved at the time of examination.
